There were no statistically significant differences between aspirin and triflusal concerning new vascular events ( 72.5 vs. 60.4 % ; p = 0.28 ) , stroke recurrence ( 49.7 vs. 46.5 % ; p = 0.53 ) , ischemic heart events ( 54.9 vs. 55.6 % ; p = 0.90 ) , vascular death ( 25.5 vs. 24 % ; p = 0.73 ) and global mortality ( 42.5 vs. 42 % ; p = 0.92 ) .